v3.26.1
Summary of Significant Accounting Policies - Schedule of Contract Assets and Deferred Revenues (Details) - DiamiR Biosciences Corp. [Member] - USD ($)
6 Months Ended 12 Months Ended
Nov. 30, 2025
May 31, 2025
May 31, 2024
Schedule of Contract Assets and Deferred Revenues [Line Items]      
Contract assets at beginning
Contract liabilities Deferred revenue at beginning
Contract assets Net change due to billings 86,373
Contract liabilities Deferred revenue Net change due to billings  
Contract assets Revenue recognized 86,373
Contract liabilities Deferred revenue Revenue recognized  
Contract assets at ending
Contract liabilities Deferred revenue at ending  
Deferred Revenue [Member]      
Schedule of Contract Assets and Deferred Revenues [Line Items]      
Contract liabilities Deferred revenue at beginning 43,982,000,000
Contract liabilities Deferred revenue Net change due to billings   43,982,000,000
Contract liabilities Deferred revenue Revenue recognized  
Contract liabilities Deferred revenue at ending   43,982,000,000
Unbilled Revenues [Member]      
Schedule of Contract Assets and Deferred Revenues [Line Items]      
Contract assets at beginning
Contract assets Net change due to billings 86,373
Contract assets Revenue recognized 86,373
Contract assets at ending